Articles by Lori Clapper
-
NICE Endorses Lundbeck's Alcohol Dependency Drug For Use In UK
7/14/2014
Lundbeck’s novel alcohol dependency drug has been endorsed by the National Institute for Health and Care Excellence (NICE) for use in Britain's state health service.
-
Spectrum's Lymphoma Drug Approved Under FDA's Accelerated Program
7/7/2014
The U.S. Food and Drug Administration (FDA) approved Spectrum Pharmaceutical’s lymphoma drug Beleodaq (belinostat). The med, manufactured for the treatment of the rare and fast-growing peripheral T-cell lymphoma (PTCL), was approved under the agency’s accelerated approval program.
-
Kyowa Hakko Kirin Announces New, Future Direction Of Kidney Disease Treatment
7/3/2014
Kyowa Hakko Kirin announced today it plans to take its small molecule compound bardoxolone methyl in a new direction, starting with a new Phase 2 clinical study on the molecule, which is currently licensed from Reata Pharmaceuticals.
-
Regulators, Doctors Say More Breast Cancer Trials Needed For Men
7/1/2014
There are 2,360 new cases and 430 deaths in men each year due to breast cancer, according to the Cancer Institute. Although these stats pale in comparison to cases in women – only one percent of all breast cancer cases — it doesn’t mean targeted therapies aren’t needed.
-
Big Pharma In Neck And Neck Race Toward Meningitis Vaccine Approval
6/20/2014
Each year, approximately 500,000 cases of meningococcal disease occur worldwide due to N. meningitidis. Not to mention, the majority of invasive meningococcal disease cases worldwide can be attributed to five N. meningitidis serogroups (A, B, C, W-135 and Y).
-
Serialization Compliance: Will Pharma Be Prepared? Part 1
5/2/2013
A Q&A With Chip Meyers, VP of UPS corporate public affairs, and Tim Bishop, manager of healthcare compliance, UPS
-
Serialization Compliance: Will Pharma Be Prepared? Part 2
5/2/2013
A Q&A With Chip Meyers, VP of UPS corporate public affairs, and Tim Bishop, manager of healthcare compliance, UPS